Autologous mesenchymal stem cells for the results of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson’s disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer’s and other CNS disorders
Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis
The C-CURE (Cardiopoietic stem Cell in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics
Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study
Mesenchymal Stem Cells as a Results for Peripheral Arterial Disease: Current Status and Potential Impact of Type II Diabetes on Their Therapeutic Efficacy
Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model
